Potent, selective and orally bioavailable p38 MAP kinase inhibitor selected as development candidate July 6, 1999
Effective and safe antiinflammatory agent with dual mechanism of action presented at congress June 29, 1999
SA-6541 effective in animal models of arthritis and dermatitis, as reported at ongoing congress June 29, 1999
RSS